Death, destruction, and the proteasome. Tansey WP (2004) N Engl J Med 351: 393-4 The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Lee D, Ezhkova E, Li B, Pattenden SG, Tansey WP, Workman JL (2005) Cell 123: 423-36 Regulation of transcriptional activation domain function by ubiquitin. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP (2001) Science 293: 1651-3 Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Verma R, Aravind L, Oania R, McDonald WH, Yates JR, Koonin EV, Deshaies RJ (2002) Science 298: 611-5 Ubiquitin and proteasomes in transcription. Geng F, Wenzel S, Tansey WP (2012) Annu Rev Biochem 81: 177-201 Transcriptional regulation: RUPture in the ER. Tansey WP (2000) Nat Cell Biol 2: E175-7 Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain. Flick K, Ouni I, Wohlschlegel JA, Capati C, McDonald WH, Yates JR, Kaiser P (2004) Nat Cell Biol 6: 634-41 Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry. Zhao W, Vaithiyalingam S, San Filippo J, Maranon DG, Jimenez-Sainz J, Fontenay GV, Kwon Y, Leung SG, Lu L, Jensen RB, Chazin WJ, Wiese C, Sung P (2015) Mol Cell 59: 176-87 Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Méndez J, Zou-Yang XH, Kim SY, Hidaka M, Tansey WP, Stillman B (2002) Mol Cell 9: 481-91 Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Ezhkova E, Tansey WP (2004) Mol Cell 13: 435-42 Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, Colbert RA (1998) J Exp Med 187: 97-104 Role of leptin and melanocortin signaling in uremia-associated cachexia. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) J Clin Invest 115: 1659-65 Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM (1998) Genes Dev 12: 1415-24 Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? Peng X, Pentassuglia L, Sawyer DB (2010) Circ Res 106: 1022-34 UNC-45a promotes myosin folding and stress fiber assembly. Lehtimäki JI, Fenix AM, Kotila TM, Balistreri G, Paavolainen L, Varjosalo M, Burnette DT, Lappalainen P (2017) J Cell Biol 216: 4053-4072 LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin. Cselenyi CS, Jernigan KK, Tahinci E, Thorne CA, Lee LA, Lee E (2008) Proc Natl Acad Sci U S A 105: 8032-7 Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL (2000) Proc Natl Acad Sci U S A 97: 9609-14 Similar temporal and spatial recruitment of native 19S and 20S proteasome subunits to transcriptionally active chromatin. Geng F, Tansey WP (2012) Proc Natl Acad Sci U S A 109: 6060-5 EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ (2008) Proc Natl Acad Sci U S A 105: 13433-8 Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Fonteneau JF, Kavanagh DG, Lirvall M, Sanders C, Cover TL, Bhardwaj N, Larsson M (2003) Blood 102: 4448-55 A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets. Su Y, Amiri KI, Horton LW, Yu Y, Ayers GD, Koehler E, Kelley MC, Puzanov I, Richmond A, Sosman JA (2010) Clin Cancer Res 16: 348-57 Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY (2005) Hum Mol Genet 14: 679-91 The proteasome: a utility tool for transcription? Collins GA, Tansey WP (2006) Curr Opin Genet Dev 16: 197-202 Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Sekhar KR, Yan XX, Freeman ML (2002) Oncogene 21: 6829-34 Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Tsang YH, Lamb A, Romero-Gallo J, Huang B, Ito K, Peek RM, Ito Y, Chen LF (2010) Oncogene 29: 5643-50 Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Li Z, Hann SR (2013) Oncogene 32: 1988-94 B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Gregory MA, Xiao Q, Cornwall GA, Lutterbach B, Hann SR (2000) Oncogene 19: 4886-95 Multiple cell-type-specific elements regulate Myc protein stability. Herbst A, Salghetti SE, Kim SY, Tansey WP (2004) Oncogene 23: 3863-71 Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway. Ando K, Shah AK, Sachdev V, Kleinstiver BP, Taylor-Parker J, Welch MM, Hu Y, Salgia R, White FM, Parvin JD, Ozonoff A, Rameh LE, Joung JK, Bharti AK (2017) Oncotarget 8: 43733-43751 Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Pellom ST, Dudimah DF, Thounaojam MC, Uzhachenko RV, Singhal A, Richmond A, Shanker A (2017) Oncotarget 8: 8604-8621 Proteolytic control of the oncoprotein transcription factor Myc. Thomas LR, Tansey WP (2011) Adv Cancer Res 110: 77-106 Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. Joseph TW, Zaika A, Moll UM (2003) FASEB J 17: 1622-30 Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. Davies SS, Amarnath V, Montine KS, Bernoud-Hubac N, Boutaud O, Montine TJ, Roberts LJ (2002) FASEB J 16: 715-7 Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells. Zeng F, Xu J, Harris RC (2009) FASEB J 23: 1935-45 Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells. Rao R, Nalluri S, Fiskus W, Balusu R, Joshi A, Mudunuru U, Buckley KM, Robbins K, Ustun C, Reuther GW, Bhalla KN (2010) Mol Cancer Ther 9: 2232-42 Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens. Dragovic SM, Hill T, Christianson GJ, Kim S, Elliott T, Scott D, Roopenian DC, Van Kaer L, Joyce S (2011) J Immunol 186: 6683-92 ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. Kanaseki T, Lind KC, Escobar H, Nagarajan N, Reyes-Vargas E, Rudd B, Rockwood AL, Van Kaer L, Sato N, Delgado JC, Shastri N (2013) J Immunol 191: 1547-55 Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. Chen M, Tabaczewski P, Truscott SM, Van Kaer L, Stroynowski I (2005) J Immunol 175: 1047-55 Killer proteases and little strokes--how the things that do not kill you make you stronger. O'Duffy AE, Bordelon YM, McLaughlin B (2007) J Cereb Blood Flow Metab 27: 655-68 Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS (2003) Mol Cell Biol 23: 4959-71
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.